
Topographer and dry eye combined
Medmont has launched its next generation Meridia Advanced Topographer, raising the bar on high-performance corneal topography combined with dry eye evaluation all in one, said the company.
4295 articles

Medmont has launched its next generation Meridia Advanced Topographer, raising the bar on high-performance corneal topography combined with dry eye evaluation all in one, said the company.

A survey of UK primary school children has shown that, on average, at least one in every class of 30 is affected by cerebral visual impairment (CVI)‐related vision problems.

A simple printed vision chart, using optotypes designed by the University of Auckland, that can be downloaded and printed has proved its worth in a recent study by Moorfields Eye Hospital in London.

The removal of the retina’s internal limiting membrane (ILM) prior to retinal ganglion cell (RGC) transplantation allows better proliferation of transplanted cells, a study has shown. Dr Thomas

Miniject, iStar Medical's micro-invasive glaucoma surgery (MIGS) device, has shown positive one-year results in its ‘Star II’ European trial. One year after surgery, 29 patients with open-angle

A retrospective study of 385 infants born at a mean gestational age of 26.4 weeks has shown that early, low-foetal haemoglobin (HbF) is associated with abnormal retinal neurovascular

A three-year clinical trial of enteral supplementation with fatty acids in premature infants has demonstrated a lowering of the risk of severe retinopathy of prematurity (ROP) by 50%. Three

Following Glaukos’ acquisition of Avedro in 2019, the company is poised to introduce a range of new corneal health products into the Australian and New Zealand markets to complement its

EviRed, a new artificial intelligence algorithm, is being ‘trained’ to predict the risk of diabetic retinopathy (DR) using modern imaging techniques. Professor Ramin Tadayoni at the University of

Glaukos has appointed Neville White as regional business manager to support the rollout of its new corneal health business in Australasia. A former orthoptist in a busy ophthalmic practice in

A study of 6,398 Covid-19-infected patients has shown that those with age-related macular degeneration (AMD) declined more rapidly, died at three times the rate of patients without AMD, and one in

Exonate has begun a 48-patient clinical trial of its EXN407 drops for diabetic macular oedema (DMO), hoping they will eventually supplant intravitreal anti-vascular endothelial growth factor (VEGF) therapy injections.